Financial Daily from THE HINDU group of publications
Tuesday, May 10, 2005
Financial Daily from THE HINDU group of publications Tuesday, May 10, 2005 |
|
|
|
|
|
Corporate
-
Announcements Micro Labs 3rd unit gets UK approval Our Bureau
Bangalore , May 9 THE Goa unit of Micro Labs has received approval of the UK-MHRA (Ministry of Health and Regulatory Affairs). The approval gives its products a foothold in the highly regulated UK and European markets as well as allows MNCs in those countries to have contract manufacturing arrangements with it. The plant is also eligible to seek approval of other European countries and also member States' PICS (Pharmaceutical Inspection Cooperation Scheme) such as Australia, New Zealand and Canada through the MRP or Mutual Recognition Procedure, a company release said. This is the third Micro Labs facility to be approved by UK-MHRA; the others are a beta-lactum facility at Bangalore and a solid dosage form facility in Hosur, Tamil Nadu. The Goa unit is fully automated with a capacity to produce 2 billion units annually on a single shift basis. This unit produces solid dosage forms including tablets and hard gelatin capsules. With these three facilities, the Rs 500-crore Micro Labs is in a position to export the solid oral dosage forms to the regulated markets. Its facilities have also been approved by the South African MCC, Health Canada, Invima Colombia and have been audited by the teams of pharmaceutical MNCs. Micro Labs manufactures and markets cardiovascular and dermatological products, ophthamological, psychotropic drugs, anti-diabetics, neurological, anti-bacterial, anti-fungal range, anti-allergenics, analgesics and women's care products.
Article E-Mail :: Comment :: Syndication :: Printer Friendly Page
|
Stories in this Section |
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |
Copyright © 2005, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|